426 related articles for article (PubMed ID: 16776827)
1. RhoA signaling modulates cyclin D1 expression in human lung fibroblasts; implications for idiopathic pulmonary fibrosis.
Watts KL; Cottrell E; Hoban PR; Spiteri MA
Respir Res; 2006 Jun; 7(1):88. PubMed ID: 16776827
[TBL] [Abstract][Full Text] [Related]
2. Simvastatin inhibits growth factor expression and modulates profibrogenic markers in lung fibroblasts.
Watts KL; Sampson EM; Schultz GS; Spiteri MA
Am J Respir Cell Mol Biol; 2005 Apr; 32(4):290-300. PubMed ID: 15677772
[TBL] [Abstract][Full Text] [Related]
3. Connective tissue growth factor expression and induction by transforming growth factor-beta is abrogated by simvastatin via a Rho signaling mechanism.
Watts KL; Spiteri MA
Am J Physiol Lung Cell Mol Physiol; 2004 Dec; 287(6):L1323-32. PubMed ID: 15298857
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of RhoA/Rho-kinase pathway suppresses the expression of type I collagen induced by TGF-beta2 in human retinal pigment epithelial cells.
Itoh Y; Kimoto K; Imaizumi M; Nakatsuka K
Exp Eye Res; 2007 Mar; 84(3):464-72. PubMed ID: 17217948
[TBL] [Abstract][Full Text] [Related]
5. Ras-stimulated extracellular signal-related kinase 1 and RhoA activities coordinate platelet-derived growth factor-induced G1 progression through the independent regulation of cyclin D1 and p27.
Weber JD; Hu W; Jefcoat SC; Raben DM; Baldassare JJ
J Biol Chem; 1997 Dec; 272(52):32966-71. PubMed ID: 9407076
[TBL] [Abstract][Full Text] [Related]
6. RhoA and Rho-kinase dependent and independent signals mediate TGF-beta-induced pulmonary endothelial cytoskeletal reorganization and permeability.
Clements RT; Minnear FL; Singer HA; Keller RS; Vincent PA
Am J Physiol Lung Cell Mol Physiol; 2005 Feb; 288(2):L294-306. PubMed ID: 15475381
[TBL] [Abstract][Full Text] [Related]
7. Transforming growth factor-beta1 (TGFbeta1) stimulates connective tissue growth factor (CCN2/CTGF) expression in human gingival fibroblasts through a RhoA-independent, Rac1/Cdc42-dependent mechanism: statins with forskolin block TGFbeta1-induced CCN2/CTGF expression.
Black SA; Trackman PC
J Biol Chem; 2008 Apr; 283(16):10835-47. PubMed ID: 18287089
[TBL] [Abstract][Full Text] [Related]
8. CCN5 overexpression inhibits profibrotic phenotypes via the PI3K/Akt signaling pathway in lung fibroblasts isolated from patients with idiopathic pulmonary fibrosis and in an in vivo model of lung fibrosis.
Zhang L; Li Y; Liang C; Yang W
Int J Mol Med; 2014 Feb; 33(2):478-86. PubMed ID: 24276150
[TBL] [Abstract][Full Text] [Related]
9. Rho-dependent inhibition of the induction of connective tissue growth factor (CTGF) by HMG CoA reductase inhibitors (statins).
Eberlein M; Heusinger-Ribeiro J; Goppelt-Struebe M
Br J Pharmacol; 2001 Aug; 133(7):1172-80. PubMed ID: 11487529
[TBL] [Abstract][Full Text] [Related]
10. RhoA promotes epidermal stem cell proliferation via PKN1-cyclin D1 signaling.
Wang F; Zhan R; Chen L; Dai X; Wang W; Guo R; Li X; Li Z; Wang L; Huang S; Shen J; Li S; Cao C
PLoS One; 2017; 12(2):e0172613. PubMed ID: 28222172
[TBL] [Abstract][Full Text] [Related]
11. 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors interfere with angiogenesis by inhibiting the geranylgeranylation of RhoA.
Park HJ; Kong D; Iruela-Arispe L; Begley U; Tang D; Galper JB
Circ Res; 2002 Jul; 91(2):143-50. PubMed ID: 12142347
[TBL] [Abstract][Full Text] [Related]
12. Effect of cyclin E overexpression on lovastatin-induced G1 arrest and RhoA inactivation in NIH3T3 cells.
Ghosh PM; Moyer ML; Mott GE; Kreisberg JI
J Cell Biochem; 1999 Sep; 74(4):532-43. PubMed ID: 10440923
[TBL] [Abstract][Full Text] [Related]
13. A Rnd3/p190RhoGAP pathway regulates RhoA activity in idiopathic pulmonary fibrosis fibroblasts.
Monaghan-Benson E; Wittchen ES; Doerschuk CM; Burridge K
Mol Biol Cell; 2018 Sep; 29(18):2165-2175. PubMed ID: 29995590
[TBL] [Abstract][Full Text] [Related]
14. Type II alveolar epithelial cells and interstitial fibroblasts express connective tissue growth factor in IPF.
Pan LH; Yamauchi K; Uzuki M; Nakanishi T; Takigawa M; Inoue H; Sawai T
Eur Respir J; 2001 Jun; 17(6):1220-7. PubMed ID: 11491168
[TBL] [Abstract][Full Text] [Related]
15. Molecular mechanism of the anti-cancer activity of cerivastatin, an inhibitor of HMG-CoA reductase, on aggressive human breast cancer cells.
Denoyelle C; Albanese P; Uzan G; Hong L; Vannier JP; Soria J; Soria C
Cell Signal; 2003 Mar; 15(3):327-38. PubMed ID: 12531431
[TBL] [Abstract][Full Text] [Related]
16. The matricellular protein CCN1 enhances TGF-β1/SMAD3-dependent profibrotic signaling in fibroblasts and contributes to fibrogenic responses to lung injury.
Kurundkar AR; Kurundkar D; Rangarajan S; Locy ML; Zhou Y; Liu RM; Zmijewski J; Thannickal VJ
FASEB J; 2016 Jun; 30(6):2135-50. PubMed ID: 26884454
[TBL] [Abstract][Full Text] [Related]
17. Pharmacological inhibition of RhoA signaling prevents connective tissue growth factor induction in endothelial cells exposed to non-uniform shear stress.
Cicha I; Goppelt-Struebe M; Muehlich S; Yilmaz A; Raaz D; Daniel WG; Garlichs CD
Atherosclerosis; 2008 Jan; 196(1):136-145. PubMed ID: 17452038
[TBL] [Abstract][Full Text] [Related]
18. Expression of connective tissue growth factor in human renal fibroblasts: regulatory roles of RhoA and cAMP.
Heusinger-Ribeiro J; Eberlein M; Wahab NA; Goppelt-Struebe M
J Am Soc Nephrol; 2001 Sep; 12(9):1853-1861. PubMed ID: 11518778
[TBL] [Abstract][Full Text] [Related]
19. Angiotensin-TGF-beta 1 crosstalk in human idiopathic pulmonary fibrosis: autocrine mechanisms in myofibroblasts and macrophages.
Uhal BD; Kim JK; Li X; Molina-Molina M
Curr Pharm Des; 2007; 13(12):1247-56. PubMed ID: 17504233
[TBL] [Abstract][Full Text] [Related]
20. Fibroblast growth factor-1 attenuates TGF-β1-induced lung fibrosis.
Shimbori C; Bellaye PS; Xia J; Gauldie J; Ask K; Ramos C; Becerril C; Pardo A; Selman M; Kolb M
J Pathol; 2016 Oct; 240(2):197-210. PubMed ID: 27425145
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
